Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant MYD88 and wildtype CD79

• Andrew L. Deng,
• Yu Ri Kim,
• Emily A. Lichtenstein,
• Owen A. O’Connor,
• Changchun Deng

Affiliations

Andrew L. Deng

Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA

Yu Ri Kim

Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA;Department of Internal Medicine, Yonsei University, Seoul, Korea

Emily A. Lichtenstein

Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA

Owen A. O’Connor

Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA

Changchun Deng

Columbia University Medical Center, Center for Lymphoid Malignancies, New York, NY, USA